Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
Mo J, Anastasaki C, Chen Z, Shipman T, Papke J, Yin K, Gutmann DH, Le LQ.
J Clin Invest. 2021 Jan 4;131(1):e139807. doi: 10.1172/JCI139807.
Tumors and tumor-like lesions of peripheral nerves.
Woertler K.
Semin Musculoskelet Radiol. 2010 Nov;14(5):547-58. doi: 10.1055/s-0030-1268073. Epub 2010 Nov 11.
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R.
Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31.
Neurofibroma and schwannoma.
Ferner RE, O'Doherty MJ.
Curr Opin Neurol. 2002 Dec;15(6):679-84. doi: 10.1097/01.wco.0000044763.39452.aa.
[Retroperitoneal Tumor: Neurofibroma.].
Lada PE, Marriot D, Sanchez Tasonne C, Sanchez M, Caballero F, Massa M.
Rev Fac Cien Med Univ Nac Cordoba. 2016;73(3):197-201.
Primary Intrabulbar Neurofibroma.
Furdová A, Babál P.
Cesk Slov Oftalmol. 2020 Spring;76(2):62-67. doi: 10.31348/2020/13.
Benign Neurogenic Tumors.
Farma JM, Porpiglia AS, Vo ET.
Surg Clin North Am. 2022 Aug;102(4):679-693. doi: 10.1016/j.suc.2022.04.007.
Neurofibroma of the hard palate.
Cartwright B, Corsar K.
BMJ Case Rep. 2021 Apr 7;14(4):e239887. doi: 10.1136/bcr-2020-239887.
Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with Nf1 Knockout in Boundary Cap Cells.
Radomska KJ, Coulpier F, Gresset A, Schmitt A, Debbiche A, Lemoine S, Wolkenstein P, Vallat JM, Charnay P, Topilko P.
Cancer Discov. 2019 Jan;9(1):130-147. doi: 10.1158/2159-8290.CD-18-0156. Epub 2018 Oct 22.
[Melanotic neurofibroma].
Sibon C, Chrétien-Marquet B, Brousse N, Fraitag S.
Ann Dermatol Venereol. 2004 Jun-Jul;131(6-7 Pt 1):583-7. doi: 10.1016/s0151-9638(04)93672-1.
